Akoya Biosciences, Inc.

    Jurisdiction
    United States
    ISIN
    US00974H1041 (AKYA)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €68.64M
    Gross margin
    61.7%
    EBIT
    -€33.10M
    EBIT margin
    -48.2%
    Net income
    -€40.80M
    Net margin
    -59.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €74.31M +8.3% -€41.05M +0.6%
    €81.37M +9.5% -€38.14M -7.1%
    €88.43M +8.7% -€31.63M -17.1%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: May 17, 2024

    Add to watchlist

    Notifications